ClassID:

97028

C07K14/705 - page 10 - CPC Classification

Classification description:

Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans Receptors; Cell surface antigens; Cell surface determinants

Recent Application in this class:
#2701
20120040456
2012-02-16

METHODS OF GENE THERAPY USING NUCLEIC ACID SEQUENCES FOR ATP-BINDING CASSETTE TRANSPORTER

#2702
20120040368
2012-02-16

Mutated voltage-gated sodium channel Naalpha subunit for identification of modulators

#2703
20120039893
2012-02-16

Mutant smoothened and methods of using the same

#2704
20120039869
2012-02-16

Methods of using molecular conjugates comprising monoclonal antibodies to dendritic cells

#2705
20120039858
2012-02-16

METHODS AND COMPOSITIONS FOR INHIBITING PROPAGATION OF VIRUSES USING RECOMBINANT TETHERIN CONSTRUCTS

#2706
20120035350
2012-02-09

Polynucleotide encoding a novel human P2X7 splice variant, HBMYP2X7v

#2707
20120034196
2012-02-09

Gene encoding a multidrug resistance human P-glycoprotein homologue on chromosome 7p15-21 and uses thereof

#2708
20120029180
2012-02-02

H-gated ion channel

#2709
20120029063
2012-02-02

Chimeric NK receptor and methods for treating cancer

#2710
20120028909
2012-02-02

Fn14/TRAIL fusion proteins and method of treating cancer

#2711
20120027764
2012-02-02

NOVEL POLYPEPTIDE, CDNA ENCODING THE SAME, AND USE THEREOF

#2712
20120027676
2012-02-02

Modified sodium iodide symporter proteins and uses thereof

#2713
20120022237
2012-01-26

Antibody to SOST peptides

#2714
20120016340
2012-01-19

COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF PROSTATE CANCER

#2715
20120016108
2012-01-19

Compositions and methods for treating kidney disease

#2716
20120015888
2012-01-19

T cell receptors and related materials and methods of use

#2717
20120015872
2012-01-19

Complement receptor 1 and 2 fusion proteins

#2718
20120015871
2012-01-19

COMPLEMENT RECEPTOR 2 TARGETED COMPLEMENT MODULATORS

#2719
20120015867
2012-01-19

Therapeutic TREM-1 peptides

#2720
20120015432
2012-01-19

Isolated nucleic acid molecules encoding bitter taste receptor polypeptides and fragments thereof

#2721
20120014959
2012-01-19

Wise/Sost nucleic acid sequences and amino acid sequences

#2722
20120014952
2012-01-19

COMPLEMENT RECEPTOR 2 TARGETED COMPLEMENT MODULATORS

#2723
20120010385
2012-01-12

Splice variants of human G-protein coupled receptor HGPRBMY29 (HGPRMBY29SV2)

#2724
20120009598
2012-01-12

Nucleic acid encoding a T2R taste receptor

#2725
20120009123
2012-01-12

Albumin binding peptide-mediated disease targeting

#2726
20120003252
2012-01-05

Isoforms of human somatostatin receptor type 5

#2727
20120003244
2012-01-05

METHODS FOR APCDD1 MEDIATED REGULATION OF HAIR GROWTH AND PIGMENTATION AND MUTANTS THEREOF

#2728
20120003231
2012-01-05

Antibodies to JTT-1 protein and cells secreting such antibodies

#2729
20110319870
2011-12-29

Method for increasing the pool of Ngn3+ endocrine progenitor cells and pancreatic endocrine cell mass

#2730
20110319602
2011-12-29

T2R taste receptors and genes encoding same

#2731
20110319286
2011-12-29

System for screening agonists/antagonists of cellular signaling pathways

#2732
20110318834
2011-12-29

Multiple-tumor aberrant growth genes

#2733
20110318380
2011-12-29

MHC Multimers in Cancer Vaccines and Immune Monitoring

#2734
20110318373
2011-12-29

Immunosuppression modulating compounds

#2735
20110318371
2011-12-29

Serpentine transmembrane antigens expressed in human cancers and uses thereof

#2736
20110312896
2011-12-22

Inhibitors of BCL-2

#2737
20110312533
2011-12-22

CELL LINES EXPRESSING NaV AND METHODS OF USING THEM

#2738
20110311558
2011-12-22

Recombinant Bone Marrow Stromal Antigen-2 in the Treatment of Autoimmune Diseases

#2739
20110311512
2011-12-22

Genetic Variants Underlying Human Cognition and Methods of Use Thereof as Diagnostic and Therapeutic Targets

#2740
20110311489
2011-12-22

Optically-based stimulation of target cells and modifications thereto

#2741
20110306558
2011-12-15

PROSAPOSIN AS A NEUROTROPHIC FACTOR

#2742
20110306040
2011-12-15

CPG RECEPTOR (CPG-R) AND METHODS RELATING THERETO

#2743
20110305709
2011-12-15

CALCIUM SENSOR STIM1 AND THE PLATELET SOC CHANNEL ORAI1 (CRACM1) ARE ESSENTIAL FOR PATHOLOGICAL THROMBUS FORMATION

#2744
20110305695
2011-12-15

Wnt Antagonists and Methods of Treatment and Screening

#2745
20110300560
2011-12-08

Members of the capsaicin/vanilloid receptor family of proteins and uses thereof

#2746
20110300160
2011-12-08

Antibodies specific for sulfated sclerostin

#2747
20110300159
2011-12-08

Sulfonated sclerostin, antibodies, epitopes and methods for identification and use therefor

#2748
20110300152
2011-12-08

Compositions and methods for modulating cell-cell fusion via intermediate-conductance calcium-activated potassium channels

#2749
20110287420
2011-11-24

Methods for identifying kremen polypeptide binding partners

#2750
20110287038
2011-11-24

METHOD FOR TREATING SOLID TUMORS

#2751
20110287029
2011-11-24

INHIBITION OF THE BETA3 SUBUNIT OF L-TYPE CA2+ CHANNELS

#2752
20110281789
2011-11-17

ULBP2 polypeptides

#2753
20110280830
2011-11-17

Albumin Fusion Proteins

#2754
20110275080
2011-11-10

Proteoglycan splice variants as therapeutics and diagnostics for amyloid diseases

#2755
20110274708
2011-11-10

Short-form human MD-2 as a negative regulator of toll-like receptor 4 signaling

#2756
20110274703
2011-11-10

Detection and treatment of non-dermal fibrosis

#2757
20110274690
2011-11-10

Compositions and methods for the diagnosis and treatment of tumor

#2758
20110271356
2011-11-03

HCV entry factor, Occludin

#2759
20110269949
2011-11-03

Methods and compositions to elicit multivalent immune responses against dominant and subdominant epitopes, expressed on cancer cells and tumor stroma

#2760
20110269941
2011-11-03

Method of loading a crystallization device

#2761
20110269939
2011-11-03

Crystal structure of human mitoNEET protein

#2762
20110269825
2011-11-03

Modified Thromboxane A2 Receptor Promoter Sequence

#2763
20110269144
2011-11-03

Ryanodine receptor polypeptides

#2764
20110268735
2011-11-03

Multimeric constructs

#2765
20110268657
2011-11-03

Compositions and methods for the treatment of tumor of hematopoietic origin

#2766
20110262968
2011-10-27

Antibodies that bind to PSCA proteins for diagnosis of cancer

#2767
20110262937
2011-10-27

In vitro methods of detecting cells sensitive to sweet tastants by detecting expression of hetero-oligomeric T1R2/T1R3 taste receptors

#2768
20110262423
2011-10-27

SUPPRESSION OF CANCER

#2769
20110262414
2011-10-27

High affinity NY-ESO T cell receptors

#2770
20110256558
2011-10-20

Method of detecting endometrial cancer comprising measuring levels of fibrocystin-L

#2771
20110256114
2011-10-20

T-cell receptor and nucleic acid encoding the receptor

#2772
20110256112
2011-10-20

Compensating for Atrioventricular Block Using a Nucleic Acid Encoding a Sodium Channel or Gap Junction Protein

#2773
20110250218
2011-10-13

Disease-Associated Antigens and Methods of Use Thereof

#2774
20110250204
2011-10-13

Methods and compositions for diagnosing and treating diseases

#2775
20110250193
2011-10-13

Composition comprising expression or activity inhibitors of ninjurin1 for the prevention and treatment of inflammatory disease

#2776
20110245772
2011-10-06

FOCAL CALCIUM CHANNEL MODULATION

#2777
20110245480
2011-10-06

Engineered Listeria and methods of use thereof

#2778
20110244563
2011-10-06

T1R3 nucleic acid fragments for use thereof as probes and for generating T1R specific antibodies

#2779
20110244516
2011-10-06

Rage Fusion Proteins And Methods Of Use

#2780
20110244514
2011-10-06

Mammalian sweet taste receptors

#2781
20110244513
2011-10-06

ISOLATED MAMMALIAN MEMBRANE PROTEIN GENES; RELATED REAGENTS

#2782
20110244493
2011-10-06

Cell-based detection of APF through its interaction with CKAP4 for diagnosis of interstitial cystitis

#2783
20110243923
2011-10-06

Methods of identifying a modulator that inhibits the binding between Epstein-Barr virus induced receptor 2 and cholesterol derived ligands

#2784
20110237519
2011-09-29

Method of reversing carboplatin resistance by inhibition of HGFIN

#2785
20110237513
2011-09-29

LTBP2 AS A BIOMARKER FOR RENAL DYSFUNCTION

#2786
20110236353
2011-09-29

ADENO-ASSOCIATED VIRUS (AAV) CLADES, SEQUENCES, VECTORS CONTAINING SAME, AND USES THEREFOR

#2787
20110236344
2011-09-29

Synthetic mimics of mammalian cell surface receptors: method and compositions

#2788
20110236313
2011-09-29

HUMAN SALTY TASTE RECEPTOR AND METHODS OF MODULATING SALTY TASTE PERCEPTION

#2789
20110231942
2011-09-22

TIKI1 AND TIKI2, WNT INHIBITORS

#2790
20110229560
2011-09-22

NLRC5 AS A TARGET FOR IMMUNE THERAPY

#2791
20110224095
2011-09-15

Expression of functional human olfactory cyclic nucleotide gated (CNG) channel in recombinant host cells and use thereof in cell based assays to identify smell modulators

#2792
20110223618
2011-09-15

Assays using chimeric T1R polypeptides for identifying putative taste modulatory compounds

#2793
20110223204
2011-09-15

TREATMENT OF PAIN WITH GAP JUNCTION MODULATION COMPOUNDS

#2794
20110223183
2011-09-15

Human Notch3 based fusion proteins as decoy inhibitors of Notch3 signaling

#2795
20110223173
2011-09-15

Methods for reducing botulinum neurotoxin A toxicity

#2796
20110223155
2011-09-15

Antagonist anti-Notch3 antibodies and their use in the prevention and treatment of Notch3-related diseases

#2797
20110223152
2011-09-15

Use of inhibitors of leukotriene B4 receptor BLT2 for treating human cancers

#2798
20110218152
2011-09-08

Compounds for stimulating P-glycoprotein function and uses thereof

#2799
20110213018
2011-09-01

Methods of treating hypertension

#2800
20110213017
2011-09-01

Targeted delivery of glycine receptors to excitable cells

#2801
20110212856
2011-09-01

Use of bitter taste receptor to screen for compounds that offset the bitter taste of chlorogenic lactone containing coffee compositions

#2802
20110212459
2011-09-01

Presenilin associated membrane protein (PAMP) and uses thereof

#2803
20110212076
2011-09-01

Viral Therapeutic

#2804
20110207213
2011-08-25

Photoreactive synthetic regulator of protein function and methods of use thereof

#2805
20110207212
2011-08-25

T1R taste receptors and genes encoding same

#2806
20110207148
2011-08-25

Cell lines expressing T1R2/T1R3 hetero-oligomeric taste receptors and assay system thereof for identification of taste compounds

#2807
20110207133
2011-08-25

Assays that detect T1R expressing cells

#2808
20110206752
2011-08-25

COMPOSITIONS FOR THE TREATMENT OF PAIN AND/OR INFLAMATION

#2809
20110206709
2011-08-25

T-cell antigen peptide from allergen for stimulation of IL-10 production

#2810
20110206658
2011-08-25

COMPOSITIONS AND METHODS FOR THE TREATMENT OF TUMOR OF HEMATOPOIETIC ORIGIN

#2811
20110201051
2011-08-18

CHEMOSENSORY GENE FAMILY ENCODING GUSTATORY AND OLFACTORY RECEPTORS AND USES THEREOF

#2812
20110201043
2011-08-18

TRANSGENIC MAMMALS AND CELL LINES FOR THE IDENTIFICATION OF GLUTAMATE TRANSPORTER MODULATORS

#2813
20110201020
2011-08-18

Methods of detecting T1R2- and T1R3-expressing cells potentially sensitive to sweet tastants

#2814
20110200608
2011-08-18

Fully human antibodies to high molecular weight-melanoma associated antigen and uses thereof

#2815
20110200605
2011-08-18

Polypeptides and use thereof

#2816
20110197290
2011-08-11

METHODS AND MATERIALS FOR PRODUCING TRANSGENIC ARTIODACTYLS

#2817
20110195908
2011-08-11

PROSAPOSIN AS A NEUROTROPHIC FACTOR

#2818
20110195901
2011-08-11

ARTERY- AND VEIN-SPECIFIC PROTEINS AND USES THEREFOR

#2819
20110195863
2011-08-11

Loss of function mutations in KCNJ10 cause SeSAME, a human syndrome with sensory, neurological, and renal deficits

#2820
20110195431
2011-08-11

Nucleic acids encoding RUP3 and methods of using same

#2821
20110189769
2011-08-04

METHODS AND COMPOSITIONS FOR MANIPULATING THE GUIDED NAVIGATION OF ENDOTHELIAL TUBES DURING ANGIOGENESIS

#2822
20110189756
2011-08-04

Method and composition for crystallizing G protein-coupled receptors

#2823
20110189199
2011-08-04

METHODS FOR P2RY5 MEDIATED REGULATION OF HAIR GROWTH AND MUTANTS THEREOF

#2824
20110185439
2011-07-28

G PROTEIN COUPLED RECEPTORS AND USES THEREOF

#2825
20110183921
2011-07-28

PEPTIDES CAPABLE OF MODULATING THE FUNCTION OF TIRC7

#2826
20110178274
2011-07-21

CANINE TRANSIENT RECEPTOR POTENTIAL V2 (CTRPV2) AND METHODS OF SCREENING FOR TRPV2 CHANNEL MODULATORS

#2827
20110178272
2011-07-21

Isolated bitter taste receptor polypeptides

#2828
20110178020
2011-07-21

Methods and compositions for inhibition of neutrophil exocytosis

#2829
20110177612
2011-07-21

Human G Protein-Coupled Receptors and Modulators Thereof for the Treatment of Metabolic-Related Disorders

#2830
20110177085
2011-07-21

Bitter taste receptors

#2831
20110177080
2011-07-21

P2X7 epitopes

#2832
20110172406
2011-07-14

Molecular structure of RHD negative

#2833
20110171728
2011-07-14

Method and composition for crystallizing G protein-coupled receptors

#2834
20110171242
2011-07-14

LIGAND FOR HERPES SIMPLEX VIRUS ENTRY MEDIATOR AND METHODS OF USE

#2835
20110171183
2011-07-14

Markers of Induced Pluripotent Stem Cells

#2836
20110166032
2011-07-07

Design and Use of Sortilin Specific Molecular Imaging Ligands

#2837
20110165936
2011-07-07

Gaming system network and method for delivering gaming media

#2838
20110165184
2011-07-07

CDH3 peptide and medicinal agent comprising the same

#2839
20110165166
2011-07-07

LSR RECEPTOR, ITS ACTIVITY, ITS CLONING, AND ITS APPLICATIONS TO THE DIAGNOSIS, PREVENTION AND/OR TREATMENT OF OBESITY AND RELATED RISKS OR COMPLICATIONS

#2840
20110165147
2011-07-07

NOVEL 18636, 2466, 43238, 1983, 52881, 2398, 45449, 50289, 52872 AND 26908 MOLECULES AND USES THEREFOR

#2841
20110164731
2011-07-07

Method and composition for crystallizing G protein-coupled receptors

#2842
20110160439
2011-06-30

Specific ligands to sortilin

#2843
20110160081
2011-06-30

FUNCTIONAL COMPLEMENTATION ASSAY FOR DEFINED GPCR OLIGOMERS

#2844
20110159953
2011-06-30

Network access device and method to run a game application

#2845
20110159952
2011-06-30

Gaming system network and method for delivering gaming media

#2846
20110159599
2011-06-30

Voltage sensor domains of voltage-dependent ion channel proteins and uses thereof

#2847
20110158947
2011-06-30

SULFONYLUREA RECEPTOR AND MEANS FOR TREATING ISCHAEMIA

#2848
20110151484
2011-06-23

hERG MUTANTS AND USES THEREOF

#2849
20110151483
2011-06-23

Mammalian sweet and amino acid heterodimeric taste receptors comprising T1R3 and T1R1

#2850
20110151473
2011-06-23

Polynucleotides and Polypeptides Encoding Receptors

#2851
20110150901
2011-06-23

Binding proteins that bind to human FGFR1C, human β-klotho and both human FGFR1C and human β-klotho

#2852
20110150761
2011-06-23

Polypeptides, polynucleotides encoding same, antibodies thereagainst and methods of using same for diagnosing and treating cancer and skeletal disorders

#2853
20110145936
2011-06-16

Genetically Modified Rat Models for Pharmacokinetics

#2854
20110144314
2011-06-16

Method for selectively extracting membrane proteins using calixarenes

#2855
20110142919
2011-06-16

Cytotoxic T-Lymphocyte-Inducing Immunogens for Prevention, Treatment and Diagnosis of Cancer

#2856
20110142763
2011-06-16

Megalin-based delivery of therapeutic compounds to the brain and other tissues

#2857
20110136223
2011-06-09

NEURTURIN RECEPTOR

#2858
20110135640
2011-06-09

IDENTIFICATION OF TUMOUR-ASSOCIATED CELL SURFACE ANTIGENS FOR DIAGNOSIS AND THERAPY

#2859
20110130345
2011-06-02

ALPHA CONNEXIN C-TERMINAL (ACT) PEPTIDES FOR TREATING AGE-RELATED MACULAR DEGENERATION

#2860
20110129905
2011-06-02

MODIFIED PICHIA STRAIN

#2861
20110129483
2011-06-02

Membrane transporter NaPi2b (SCL34A1) epitope for antibody therapy, antibodies directed thereto, and target for cancer therapy

#2862
20110129477
2011-06-02

NOGO Receptor Homologs

#2863
20110129449
2011-06-02

COMPENSATING FOR ATRIOVENTRICULAR BLOCK USING A NUCLEIC ACID ENCODING A SODIUM CHANNEL OR GAP JUNCTION PROTEIN

#2864
20110126302
2011-05-26

Diagnostic and therapeutic methods for EFMR (epilepsy and mental retardation limited to females)

#2865
20110126301
2011-05-26

Dendritic cell marker and uses thereof

#2866
20110124102
2011-05-26

Rage Fusion Proteins And Methods Of Use

#2867
20110123535
2011-05-26

Use of Nogo Receptor-1 (NGR1) for Promoting Oligodendrocyte Survival

#2868
20110118188
2011-05-19

Factor VIII polypeptide having factor VIII:C activity

#2869
20110117573
2011-05-19

Cell division marker

#2870
20110117115
2011-05-19

Method and vaccine comprising copolymer 1 for treatment of psychiatric disorders

#2871
20110117112
2011-05-19

Sodium channel protein type III α-subunit splice variant

#2872
20110117094
2011-05-19

Reactivation of axon growth and recovery in chronic spinal cord injury

#2873
20110112179
2011-05-12

Cell line, system and method for optical control of secondary messengers

#2874
20110112177
2011-05-12

Human G-Protein Coupled Receptor (HETGQ23)

#2875
20110112012
2011-05-12

Novel Protein for Binding Bacillus Thuringiensis Cry Toxins and Fragments of Cadherins for Enhancing Cry Toxicity Against Dipterans

#2876
20110110959
2011-05-12

Antibodies for binding to non-functional P2Xreceptors in trimeric form

#2877
20110110938
2011-05-12

Compositions and methods for the treatment of immune related diseases

#2878
20110105741
2011-05-05

Nucleic acids encoding a G-protein coupled receptor involved in sensory transduction

#2879
20110104801
2011-05-05

METHODS AND COMPOSITIONS FOR CELL-CYCLE REGULATION

#2880
20110104711
2011-05-05

Methods of identifying modulators of GPR81 receptors

#2881
20110104665
2011-05-05

MUTANT SODIUM CHANNEL NAV 1.7 AND METHODS RELATED THERETO

#2882
20110104120
2011-05-05

Directed evolution and in vivo panning of virus vectors

#2883
20110104059
2011-05-05

Membrane Associated Tumor Endothelium Markers

#2884
20110098191
2011-04-28

IN VITRO METHODS FOR DETECTING RENAL CANCER

#2885
20110097741
2011-04-28

PARTIAL T1R2 NUCLEIC ACID SEQUENCE, RECEPTOR PROTEIN AND ITS USE IN SCREENING ASSAYS

#2886
20110097739
2011-04-28

BLOOD-BRAIN BARRIER EPITOPES AND USES THEREOF

#2887
20110097334
2011-04-28

Marker genes for regulatory T cells from human blood

#2888
20110092674
2011-04-21

Non-functional P2Xreceptor

#2889
20110092670
2011-04-21

Variants derived from ActRIIB and uses therefor

#2890
20110091467
2011-04-21

Compositions and methods for modulating dopamine neurotransmission

#2891
20110091464
2011-04-21

Proteins and methods for modulating cell activity

#2892
20110091454
2011-04-21

METHODS AND SYSTEMS FOR ANNOTATING BIOMOLECULAR SEQUENCES

#2893
20110091448
2011-04-21

Methods for regulation of stem cells

#2894
20110091425
2011-04-21

Upregulation of opioid receptors for management

#2895
20110086903
2011-04-14

Emergence of a R-type CA2+ channel (CAV 2.3) contributes to cerebral artery constriction following subarachnoid hemorrhage

#2896
20110086775
2011-04-14

H-gated ion channel

#2897
20110086768
2011-04-14

Transferrin fusion protein libraries

#2898
20110086389
2011-04-14

Compositions and Methods for Expressing In-Frame Multimeric Proteins

#2899
20110086345
2011-04-14

Ryanodine receptor polypeptides

#2900
20110082220
2011-04-07

PORCINE UMAMI TASTE RECEPTORS AND USES THEREFOR

#2901
20110081658
2011-04-07

T1R3 binding assays

#2902
20110081656
2011-04-07

Methods of identifying compounds that bind TANGO240

#2903
20110077702
2011-03-31

Means and Methods for Influencing Electrical Activity of Cells

#2904
20110076304
2011-03-31

ADAPTER MOLECULE FOR THE DELIVERY OF ADENOVIRUS VECTORS

#2905
20110071198
2011-03-24

NICOTINIC ACID RECEPTOR LIGANDS

#2906
20110070243
2011-03-24

COMPOSITIONS AND METHODS FOR THE TREATMENT OF TUMOR OF HEMATOPOIETIC

#2907
20110070233
2011-03-24

ACTRIIB ANTAGONISTS AND DOSING AND USES THEREOF

#2908
20110070208
2011-03-24

T-cell having a T-cell receptor that recognizes epitope HBC18-27 of hepatitis B viral core antigen

#2909
20110065147
2011-03-17

Polynucleotide encoding an ATP binding cassette transporter 1 (ABC1) polypeptide

#2910
20110065124
2011-03-17

Methods of identifying compounds that bind TANGO509

#2911
20110064654
2011-03-17

Prostate cancer diagnosis and treatment

#2912
20110059549
2011-03-10

METHODS AND SYSTEMS FOR PRODUCING NANOLIPOPROTEIN PARTICLES

#2913
20110059173
2011-03-10

Compositions and methods for promoting wound healing and tissue regeneration

#2914
20110059068
2011-03-10

Polypeptides involved in immune response

#2915
20110055936
2011-03-03

TRANSGENIC MAMALS MODIFIELD IN BRI PROTEIN EXPRESSION

#2916
20110053184
2011-03-03

Methods of identifying modulators of bitter taste using hT2R50 receptors

#2917
20110053165
2011-03-03

CACNB2 nucleic acid mutations as indicators of shorter than normal QT interval and ST segment elevation associated with sudden cardiac death

#2918
20110053137
2011-03-03

Methods of identifying modulators of a cold-and-menthol-sensitive receptor (CMR1) and recombinant cells for use thereof

#2919
20110052554
2011-03-03

Methods for off-the-shelf tumor immunotherapy using allogeneic T-cell precursors

#2920
20110052529
2011-03-03

METHODS AND COMPOSITIONS FOR EXPANDING T REGULATORY CELLS

#2921
20110045003
2011-02-24

CADHERIN-11 ANTAGONISTS AND METHODS FOR THE TREATMENT OF INFLAMMATORY JOINT DISORDERS

#2922
20110042260
2011-02-24

COMPOSITIONS AND METHODS FOR THE TREATMENT OF TUMOR OF HEMATOPOIETIC ORIGIN

#2923
20110041190
2011-02-17

NOVEL CHIMERIC PROTEINS

#2924
20110039784
2011-02-17

COMPOSITION FOR TREATMENT OF ERECTILE DYSFUNCTION

#2925
20110039780
2011-02-17

PLATELET GLYCOPROTEIN IB ALPHA VARIANT FUSION POLYPEPTIDES AND METHODS OF USE THEREOF

#2926
20110039758
2011-02-17

Molecular Interactions in Neurons

#2927
20110038892
2011-02-17

COMPLEXING SYSTEM

#2928
20110038842
2011-02-17

High affinity NY-ESO T cell receptor

#2929
20110035816
2011-02-10

Genetically Modified Rat Models for Drug Metabolism

#2930
20110034533
2011-02-10

Compositions and methods modulating MG29 for the treatment of diabetes

#2931
20110033929
2011-02-10

USES OF ANTIBODIES TO MAMMALIAN DC LANGERHANS CELL ANTIGEN

#2932
20110033892
2011-02-10

Members of the capsaicin/vanilloid receptor family of proteins and uses thereof

#2933
20110033481
2011-02-10

PROSPECTIVE IDENTIFICATION AND CHARACTERIZATION OF BREAST CANCER STEM CELLS

#2934
20110033470
2011-02-10

Human G-Protein Coupled Receptor

#2935
20110033469
2011-02-10

Leukotriene B4 binding soluble lipocalin receptor from ixodes ricinus

#2936
20110033464
2011-02-10

IMMUNOGLOBULIN FUSION PROTEIN FORMULATIONS

#2937
20110033383
2011-02-10

Methods and compositions for generating an immune response by inducing CD40 and pattern recognition receptors and adaptors thereof

#2938
20110031438
2011-02-10

Methods and compositions for obtaining high-resolution crystals of membrane proteins

#2939
20110030071
2011-02-03

Transgenic Animal Model of Cancer and Methods of Use

#2940
20110028689
2011-02-03

Nucleic acids that encode sodium channel

#2941
20110028384
2011-02-03

RAP variants for drug delivery and methods of use thereof

#2942
20110028383
2011-02-03

Activated amino- and carboxy-terminal forms of Notch

#2943
20110027911
2011-02-03

SOLUBILIZATION AND STUDY OF MEMBRANE PROTEINS

#2944
20110027910
2011-02-03

Screening

#2945
20110027807
2011-02-03

Antibodies specific for ZNT8

#2946
20110027187
2011-02-03

Therapeutic or prophylactic agent, detection method and detection agent for metabolic syndrome, and method for screening of candidate compound for therapeutic agent for metabolic syndrome

#2947
20110027176
2011-02-03

Homing peptide for tumor vasculature

#2948
20110021760
2011-01-27

CRYSTALLINE VAP-1 AND USES THEREOF

#2949
20110021375
2011-01-27

Sphingosine 1-phosphate receptor gene, SPPR

#2950
20110020910
2011-01-27

Methods and compositions for improving sugar transport, mixed sugar fermentation, and production of biofuels

#2951
20110020810
2011-01-27

TRPC6 involved in glomerulonephritis

#2952
20110020798
2011-01-27

Novel italy, LOR-2, strife, trash, BDSF, LRSG, and STMST protein and nucleic acid molecules and uses therefor

#2953
20110020354
2011-01-27

Antibodies and functional fragments thereof that specifically bind an RF-amide peptide or a precursor thereof

#2954
20110020351
2011-01-27

Polypeptide ESDN, polynucleotides encoding the polypeptide, and utility of the polypeptide

#2955
20110020341
2011-01-27

Multidrug resistance-associated polypeptide

#2956
20110020267
2011-01-27

Tweak receptor

#2957
20110015138
2011-01-20

Inhibition of inflammation using antagonists of MUC1

#2958
20110015127
2011-01-20

Targeting complement factor H for treatment of diseases

#2959
20110014659
2011-01-20

Isolation of unknown rearranged T-cell receptors from single cells

#2960
20110014634
2011-01-20

NUCLEIC ACIDS ENCODING T2R, A NOVEL FAMILY OF TASTE RECEPTORS

#2961
20110014169
2011-01-20

High affinity NY-ESO T cell receptors

#2962
20110014160
2011-01-20

DDR1-mediated cell purification of pancreatic endocrine cells through their progenitors

#2963
20110009603
2011-01-13

Method and composition for crystallizing G protein-coupled receptors

#2964
20110009430
2011-01-13

Methods and compositions for treating asthma

#2965
20110009312
2011-01-13

Albumin fusion proteins

#2966
20110008769
2011-01-13

Dopaminergic neuron progenitor cell marker 187A5

#2967
20110008352
2011-01-13

Toll-like receptor 3 antagonists

#2968
20110008342
2011-01-13

Compositions of humanized notch fusion proteins and methods of treatment

#2969
20110008323
2011-01-13

Cadherin-11 EC1 domain antagonists for treating inflammatory joint disorders

#2970
20110008212
2011-01-13

CHEMICAL SENSOR HAVING SENSITIVE FILM IMITATING OLFACTORY RECEPTOR

#2971
20110004952
2011-01-06

Method for the separation of cells

#2972
20110003971
2011-01-06

MODULATORS AND MODULATION OF THE INTERACTION BETWEEN RGM AND NEOGENIN

#2973
20110003756
2011-01-06

C5a Receptor Antagonists

#2974
20110003711
2011-01-06

CELL LINES EXPRESSING GABA RECEPTOR AND METHODS USING THEM

#2975
20110003385
2011-01-06

REGULATED TRANSCRIPTION OF TARGETED GENES AND OTHER BIOLOGICAL EVENTS

#2976
20110002938
2011-01-06

HEMATOPOIETIC CELLS EXPRESSING THE PROTEIN KRTCAP3 AND LIGANDS FOR THE PROTEIN KRTCAP3

#2977
20100330697
2010-12-30

COMPLEXES OF TRPC DOMAINS AND SESTD1 DOMAINS AND METHODS AND USES INVOLVING THE SAME

#2978
20100330590
2010-12-30

Assays using chimeric T1R3 taste receptor polypeptides

#2979
20100330572
2010-12-30

ORGANIC COMPOUNDS

#2980
20100330067
2010-12-30

Methods for suppressing Toll-like Receptor 4 (TLR4) function using TLR14 antagonists

#2981
20100323420
2010-12-23

Regulated apoptosis

#2982
20100323375
2010-12-23

AGENT AND METHOD FOR DIAGNOSIS ON THE OCCURRENCE OF ALZHEIMER'S DISEASE OR THE TENDENCY TO DEVELOP ALZHEIMER'S DISEASE

#2983
20100323371
2010-12-23

STROMAL INTERACTING MOLECULE KNOCKOUT MOUSE AND USES THEREOF

#2984
20100322948
2010-12-23

Bone morphogenetic protein (BMP)-binding domains of proteins of the repulsive guidance molecule (RGM) protein family and functional fragments thereof, and use of same

#2985
20100322926
2010-12-23

METHODS OF USING CADHERIN 11 (CDH11) ANTAGONISTS

#2986
20100322913
2010-12-23

Chimeric polypeptide comprising the fragment B of shiga toxin and peptides of therapeutic interest

#2987
20100322850
2010-12-23

Plasma membrane biomarkers preferentially expressed in pancreatic beta cells useful in imaging or targeting beta cells

#2988
20100319076
2010-12-16

Transgenic non-human animals for pharmacological and toxicological studies

#2989
20100317571
2010-12-16

Methods for reducing CD36 expression

#2990
20100317098
2010-12-16

Nucleic acid molecules encoding soluble frizzled (FZD) receptors

#2991
20100317003
2010-12-16

NOVEL COMPOSITIONS AND METHODS IN CANCER WITH ALTERED EXPRESSION OF KCNJ9

#2992
20100316570
2010-12-16

Protection of virus particles from phagocytosis by expression of CD47

#2993
20100316569
2010-12-16

Peptides

#2994
20100311809
2010-12-09

VIRAL VECTOR SYSTEM, A COMPOSITION COMPRISING THE VIRAL VECTOR SYSTEM AND ITS USE

#2995
20100311610
2010-12-09

CELL LINES AND METHODS FOR MAKING AND USING THEM (As Amended)

#2996
20100310452
2010-12-09

PROSTATE-SPECIFIC MEMBRANE ANTIGEN AND USES THEREOF

#2997
20100304402
2010-12-02

CHIMERIC HUMAN SWEET-UMAMI AND UMAMI-SWEET TASTE RECEPTORS

#2998
20100303897
2010-12-02

ADDL receptor polypeptides, polynucleotides and host cells for recombinant production

#2999
20100303829
2010-12-02

HIV VPR-specific T cell receptors

#3000
20100303819
2010-12-02

DCL-1 AND USES THEREOF